Abstract 138: Effectiveness and Safety of Apixaban Compared to Warfarin among Venous Thromboembolism Patients in the United States Medicare Population

Patrick Hlavacek,Jennifer D Guo,Lisa Rosenblatt,Allison Keshishian,Cristina Russ,Jack Mardekian,Mauricio Ferri,Tayla Poretta,Huseyin Yuce,Robert D. McBane

Abstract 138: Effectiveness and Safety of Apixaban Compared to Warfarin among Venous Thromboembolism Patients in the United States Medicare Population

2019

Patrick Hlavacek
Jennifer D Guo
Lisa Rosenblatt
Allison Keshishian
Cristina Russ
Jack Mardekian
Mauricio Ferri
Tayla Poretta
Huseyin Yuce
Robert D. McBane

Background: The AMPLIFY randomized clinical trial showed that apixaban was associated with significantly lower major bleeding (MB) compared to warfarin for patients with venous thromboembolism (VTE...

Keywords:

Medical emergency
Emergency medicine
Medicine
Population
Apixaban
Warfarin
Randomized controlled trial
venous thromboembolism
Physical therapy
medicare population
major bleeding
Pulmonary embolism

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations